与耐治疗高血压相关的因素:前性观察性研究的结果
Mohammed Awais Hameed1,2, Mohamed Elsadig1,3, Shakil Ahmad4
1University Hospitals Birmingham NHS Foundation Trust.
Journal of hypertension
|December 29, 2025
概括
耐治疗高血压 (TRH) 与更高的心脏生物标志物 (如NT-proBNP) 有关. 识别这些因素对于理解和管理TRH至关重要,改善患者的治疗结果.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 高血压研究 高血压研究
背景情况:
- 耐治疗高血压 (TRH) 影响的是未经≥3种药物控制的患者.
- TRH增加了心血管事件,脏疾病和死亡率的风险.
- 由于白衣高血压,不坚持和不适当的药物组合,TRH的患病率经常被高估.
研究的目的:
- 调查与真正的耐治疗高血压 (TRH) 相关的因素.
- 为了区分真正的TRH与其他导致失控血压的原因.
主要方法:
- 治疗高血压的成年患者的综合评估.
- 评估包括内皮功能,身体组成,动脉硬,睡眠研究和生物标志物分析.
- 真正的TRH患者和非TRH患者之间的比较.
主要成果:
- 在141名患者中,60名 (43%) 患有真正的TRH.
- TRH患者年龄较大,高血压持续时间较长,糖尿病较多.
- 在TRH患者中观察到较高的左心室缩,细胞外水,尿蛋白和心脏/炎症生物标志物 (NT-proBNP,hs-troponin,自由光链,Endothelin-1) 的比率.
- 多变量分析发现NT-proBNP是唯一与TRH相关的显著因素 (P=.027).
结论:
- 这项FACT-RHY研究为TRH.的潜在病理生理机制提供了洞察力.
- 结果强调需要对TRH机制进行进一步研究.
- 对TRH的潜在管理策略进行进一步调查是有必要的.
相关概念视频
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
437
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
437
01:28Factors affecting Blood pressure
6.3K
Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
Physiological Factors:
6.3K
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications
564
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
564
01:18Hypertension and Regulation of Blood Pressure
3.6K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.6K
01:29Hypertension II: Pathophysiology
700
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
700
01:28Hypertension I: Introduction
659
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
659